Lancet (London, England), 377 (9774), 13411352
Improved glucose stability Because GLP-1 medications were originally developed for type 2 diabetes, there is evidence from clinical trials to indicate their positive effect on glucose stability, at even lower doses than those needed for maximal weight loss
Such was the case in the 1980s, when gastroenterologist Jean-Pierre Raufman and biochemist John Pisano conducted experiments in which they injected various animal venoms into guinea pig pancreases
Documented Attributes Key catalog attributes for this material include: Research-grade material intended for laboratory investigation only Catalog labeling aligned with research procurement channels Suitable for method development and comparative assay workflows Documentation packages available where provided for the listed lot Laboratory Handling Notes Receiving and Identity Checks Before opening a vial of Dihexa Peptide , confirm the physical label against the purchase order and packing list
Not because it cures everything, but because it can help with almost everything